These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 12417536)
21. ECGs in the ED. Tanel RE Pediatr Emerg Care; 2005 Nov; 21(11):795-6. PubMed ID: 16280960 [No Abstract] [Full Text] [Related]
22. Hypertrophic cardiomyopathy. Santos Mateo JJ; Sabater Molina M; Gimeno Blanes JR Med Clin (Barc); 2018 Jun; 150(11):434-442. PubMed ID: 29150126 [TBL] [Abstract][Full Text] [Related]
23. [Sudden cardiac death in familial hypertrophic cardiomyopathy. Identification of high-risk patients]. Pellnitz C; Geier C; Perrot A; Dietz R; Osterziel KJ; Haverkamp W Dtsch Med Wochenschr; 2005 May; 130(18):1150-4. PubMed ID: 15856398 [TBL] [Abstract][Full Text] [Related]
24. [Hypertrophic cardiomyopathy: DNA diagnosis, genetic counselling and the risk of sudden cardiac death]. Baars HF; Christiaans I; de Nijs PT; Cramer MJ; van Langen IM; Doevendans PA Ned Tijdschr Geneeskd; 2010; 154():A698. PubMed ID: 20132578 [TBL] [Abstract][Full Text] [Related]
25. Apico-aortic conduit for severe hypertrophic cardiomyopathy: sudden death despite conduit patency 31 years postoperatively. Nappi G; Dialetto G; De Feo M; Provenzano R; Cotrufo M; Santè P; Della Corte A Ann Thorac Cardiovasc Surg; 2013; 19(1):63-6. PubMed ID: 22785550 [TBL] [Abstract][Full Text] [Related]
26. Prevention of sudden death in hypertrophic cardiomyopathy: but which defibrillator for which patient? Boriani G; Maron BJ; Shen WK; Spirito P Circulation; 2004 Oct; 110(15):e438-42. PubMed ID: 15477422 [No Abstract] [Full Text] [Related]
27. [Familial hypertrophic cardiomyopathy associated with Wolff-Parkinson-White syndrome revealing type II glycogenosis]. Tabarki B; Mahdhaoui A; Yacoub M; Selmi H; Mahdhaoui N; Bouraoui H; Ernez S; Jridi G; Ammar H; Essoussi AS Arch Pediatr; 2002 Jul; 9(7):697-700. PubMed ID: 12162158 [TBL] [Abstract][Full Text] [Related]
35. Hypertrophic cardiomyopathy: the importance of arrhythmic events in patients at risk for sudden cardiac death. Medeiros Pde T; Martinelli Filho M; Arteaga E; Costa R; Siqueira S; Mady C; Piegas LS; Ramires JA Arq Bras Cardiol; 2006 Nov; 87(5):649-57. PubMed ID: 17221043 [TBL] [Abstract][Full Text] [Related]
36. Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease? Bonaventura J; Rowin EJ; Maron MS; Maron BJ J Am Heart Assoc; 2023 Jun; 12(12):e028974. PubMed ID: 37301765 [No Abstract] [Full Text] [Related]
37. [Syncope of uncertain cause and sudden cardiac death in young patients]. Schimpf R; Wolpert C; Veltmann C; Kuschyk J; Borggrefe M Dtsch Med Wochenschr; 2006 May; 131(18):1040-6. PubMed ID: 16673231 [No Abstract] [Full Text] [Related]
38. The discovery of Naxos disease. Eur Heart J; 2009 Nov; 30(21):2546-8. PubMed ID: 19891084 [No Abstract] [Full Text] [Related]
39. A good idea: a physician's perspective on genetic counseling for hypertrophic cardiomyopathy. Patterson C J Cardiovasc Transl Res; 2009 Dec; 2(4):508-9. PubMed ID: 20560009 [No Abstract] [Full Text] [Related]
40. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]